P2176
P3781
Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGDCollection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal VolunteersA Dose Finding Study of CycloSam® Combined With External Beam RadiotherapyLentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype ASafety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal ImpairmentThe Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem CellsEvaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell CollectionPlerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesPlerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple MyelomaA Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell TransplantationPlerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid LeukemiaWhole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With GlioblastomaSafety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease
P4844
AMD3100/CXCR4 InhibitorPlerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100CXCR4-Targeted Nanocarriers for Triple Negative Breast CancersPhysiology and pharmacology of plerixafor.Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats.Inhibition of HIV fusion by small molecule agonists through efficacy-engineering of CXCR4.Plerixafor and related macrocyclic amines are potential drug candidates in treatment of malaria by "filling the flap" region of plasmepsin enzymesForkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug AdministrationThe interaction of Mozobil™ with carboxylatesDefining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imagingPlerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells
P921
Q60501336-C632EC30-9B82-4720-A839-75770615E090Q61865028-D165837C-3835-41A3-A714-B190CF600000Q61905150-4B7C78B4-D73F-46C6-AA35-D787438606E9Q61909476-738C6810-6C83-4E0B-A218-3F6A91560C14Q61924631-5715FBA0-BA93-4E92-9E33-E6E58D2A834AQ61924675-F00AD0E1-3B4D-4387-AFA7-9A9308556716Q61936480-E808C23D-18D0-4A8A-A49E-71EEB3402EA4Q61936631-8C3B14C4-A9CF-428D-9B75-3BD4481A7070Q61938152-7C0177DD-CA7E-4964-A993-5AE7842D9D76Q61938392-964889A9-8B08-48E3-832F-9E0B7F264611Q61939056-37E7B935-5D22-452A-872D-8083F319C19CQ61939402-189FCBB0-1DD7-4C79-85AE-BEF79B9BC9E3Q61966186-9EB539D8-5535-49DB-962D-C83635A4DCBEQ62034451-F18341B0-F2D4-4156-92B5-C40574877AF9Q62062039-B2770DC9-32E8-4FE4-A85F-CEA90D1E96D3
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Pleriksafor
@sh
Pleriksafor
@sr
Plerixafor
@de
Plerixafor
@fr
Plerixafor
@vi
pleriksafor
@nn
plerixafor
@en
plerixafor
@pt
بليريكسافور
@ar
پلریکسافور
@fa
type
label
Pleriksafor
@sh
Pleriksafor
@sr
Plerixafor
@de
Plerixafor
@fr
Plerixafor
@vi
pleriksafor
@nn
plerixafor
@en
plerixafor
@pt
بليريكسافور
@ar
پلریکسافور
@fa
altLabel
AMD 3100
@en
AMD3100
@de
AMD3100
@en
JM 3100
@en
Mozobil
@pt
Mozobil®
@en
bicyclam JM-2987
@en
plerixafor
@nn
prefLabel
Pleriksafor
@sh
Pleriksafor
@sr
Plerixafor
@de
Plerixafor
@fr
Plerixafor
@vi
pleriksafor
@nn
plerixafor
@en
plerixafor
@pt
بليريكسافور
@ar
پلریکسافور
@fa
P129
P592
P6366
P661
P662
P665
P683
P2067
P2115
N0000177944
P2275
Plerixafor
@en
P231
110078-46-1
P233
C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3
P234
1S/C28H54N8/c1-9-29-15-17-31-1 ...... 0-24-36/h5-8,29-34H,1-4,9-26H2
P235
YIQPUIGJQJDJOS-UHFFFAOYSA-N